Identification of Novel Antagonists for Rab38 Protein by Homology Modeling and Virtual Screening

Aboubakr Haredi Abdelmonsef, Ramasree Dulapalli, Thirupathi Dasari

  • 1Department of Chemistry, University College of Science, Osmania University, Hyderabad 500007, Telangana, India.. India.

Abstract

Insights

Researchers identified potential new cancer drugs by computationally targeting the Rab38 protein, which is overexpressed in melanoma. This study focused on finding novel inhibitors for Rab38 to combat melanoma cancer.

Area of Science:

  • Computational drug discovery
  • Molecular biology
  • Cancer research

Background:

  • Rab proteins regulate membrane trafficking, cell growth, and differentiation.
  • Rab38 is crucial for melanosome biogenesis and is overexpressed in melanoma.
  • Melanoma is a significant form of skin cancer.

Purpose of the Study:

  • To identify novel antagonists of the Rab38 protein as potential cancer drug candidates.
  • To computationally screen for compounds that inhibit Rab38 activity.

Main Methods:

  • Homology modeling was used to generate the 3D structure of Rab38.
  • Active site identification and protein-protein docking were performed using computational tools.
  • Virtual screening was employed to identify potential inhibitors of Rab38.

Main Results:

  • Key residues (SER35 to LEU63) important for ligand binding were identified.
  • Nineteen docked structures with favorable binding at the active site were obtained.
  • Compounds showed good glide scores, indicating potential inhibitory activity.

Conclusions:

  • Benzosulfonamide and heterocyclic nitrogen moieties are promising pharmacophores for designing Rab38 inhibitors.
  • The identified compounds represent potential leads for developing new anticancer drugs against melanoma.
  • This study aids in discovering inhibitors for Rab38, targeting melanoma cancer.